glp-1 drugs eli lilly Lilly's oral pill may help people with Type 2 diabetes lose 'significant' weight, study finds Lilly is now pharma's top

5,12,13 These efforts have yielded six GLP-1 RAsstarting with the development of exendin-4 (Figure 1B)-based exenatide (Figure 1C), followed by liraglutide (Figure 1D), albiglutide, dulaglutide (Figure 1E), lixisenatide, and semaglutide (Figure 1F)that have been approved by the United States Food and Drug Administration (US FDA) to treat type 2 diabetes

A treatment with DPP-4 inhibitors should be stopped when GLP-1 receptor agonists are used

J.Mietlicki-BaaseE

In clinical trials, GLP-1s enhanced smoking cessation outcomes when paired with nicotine patches

doi:10.1080/17512433.2025.2450254

While GLP-1 users often face digestive side effects like bloating or nausea, a proactive nutrition approach strengthens the gut instead of stressing it